Literature DB >> 3128606

In vivo effects of monoclonal anti-L3T4 antibody on immune responsiveness of mice infected with Schistosoma mansoni. Reduction of irradiated cercariae-induced resistance.

E A Kelly1, D G Colley.   

Abstract

Mice can be partially protected against challenge infections of Schistosoma mansoni cercariae by either single or multiple exposure to irradiated cercariae (x-cerc). The participation of L3T4+ lymphocytes on this resistance phenomenon was evaluated by selectively depleting this cell population through in vivo administration of mAb anti-L3T4 (hybridoma GK 1.5) at three different times in relationship to the challenge infections. Treatment with anti-L3T4 before challenge such that depletion was effective during the time of cercarial skin penetration and dermal/s.c. residence significantly reduced the level of resistance induced by x-cerc sensitization. When treatment was delayed until after challenge, depletion of L3T4+ cells coincided with either the lung or post-lung/liver phases of schistosomular migration, and normal levels of x-cerc-induced resistance were induced. In contrast to once-immunized mice, mice hyperimmunized by five exposures to x-cerc and then depleted of L3T4+ cells at the time of challenge (skin phase) still expressed resistance to the challenge. These data suggest that when mice are sensitized only once with x-cerc the challenge infection provides a necessary immunologic boost which requires L3T4+ cells for effective expression of resistance. The requirement for this anamnestic effect by the challenge infection can be circumvented by hyperimmunization. Evaluation of the immune response of one-time sensitized or hyperimmunized mice demonstrated that cellular Ag-specific proliferative responses and mitogen-induced lymphokine production were abrogated after any of the various in vivo regimens of anti-L3T4 antibody. In contrast, immunoblot analysis of humoral responsiveness revealed a correlation between the expression of resistance and the ability of sera from immunized and anti-L3T4 treated mice to recognize a 75-kDa parasite antigenic component.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3128606

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  21 in total

1.  Interleukin-12 as an adjuvant for an antischistosome vaccine consisting of adult worm antigens: protection of rats from cercarial challenge.

Authors:  R D Bungiro; M Goldberg; P K Suri; P M Knopf
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

2.  Depletion of L3T4+ (CD4+) T lymphocytes prevents development of resistance to Toxoplasma gondii in mice.

Authors:  F G Araujo
Journal:  Infect Immun       Date:  1991-05       Impact factor: 3.441

3.  A role for CD4+ but not CD8+ T cells in immunity to Schistosoma mansoni induced by 20 krad-irradiated and Ro 11-3128-terminated infections.

Authors:  D A Vignali; P Crocker; Q D Bickle; S Cobbold; H Waldmann; M G Taylor
Journal:  Immunology       Date:  1989-08       Impact factor: 7.397

4.  Role of epidermal Langerhans' cells in the induction of protective immunity to Schistosoma mansoni in guinea-pigs.

Authors:  H Sato; H Kamiya
Journal:  Immunology       Date:  1995-02       Impact factor: 7.397

5.  T-helper type-1-dominated lymph node responses induced in C57BL/6 mice by optimally irradiated cercariae of Schistosoma mansoni are down-regulated after challenge infection.

Authors:  R M Pemberton; R A Wilson
Journal:  Immunology       Date:  1995-02       Impact factor: 7.397

6.  Patterns of cytokine production and proliferation by T lymphocytes differ in mice vaccinated or infected with Schistosoma mansoni.

Authors:  R M Pemberton; L E Smythies; A P Mountford; R A Wilson
Journal:  Immunology       Date:  1991-07       Impact factor: 7.397

7.  Role of T lymphocyte subsets in the pathogenesis of primary infection and rechallenge with respiratory syncytial virus in mice.

Authors:  B S Graham; L A Bunton; P F Wright; D T Karzon
Journal:  J Clin Invest       Date:  1991-09       Impact factor: 14.808

8.  Immunity after treatment of human schistosomiasis: association between cellular responses and resistance to reinfection.

Authors:  M Roberts; A E Butterworth; G Kimani; T Kamau; A J Fulford; D W Dunne; J H Ouma; R F Sturrock
Journal:  Infect Immun       Date:  1993-12       Impact factor: 3.441

9.  The generation of interferon-gamma-producing T lymphocytes in skin-draining lymph nodes, and their recruitment to the lungs, is associated with protective immunity to Schistosoma mansoni.

Authors:  A P Mountford; P S Coulson; R M Pemberton; L E Smythies; R A Wilson
Journal:  Immunology       Date:  1992-02       Impact factor: 7.397

10.  A Schistosoma japonicum chimeric protein with a novel adjuvant induced a polarized Th1 immune response and protection against liver egg burdens.

Authors:  Xindong Xu; Dongmei Zhang; Wei Sun; Qingfeng Zhang; Jingjing Zhang; Xiangyang Xue; Luhui Shen; Weiqing Pan
Journal:  BMC Infect Dis       Date:  2009-05-06       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.